{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:05:44Z","timestamp":1794002744382,"version":"4.8.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41409-025-02555-9","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T09:04:58Z","timestamp":1742720698000},"page":"697-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-8084","authenticated-orcid":false,"given":"Nicole","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7070-487X","authenticated-orcid":false,"given":"Christoph","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7470-2994","authenticated-orcid":false,"given":"Moniek","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke W. H.","family":"Roeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8858-923X","authenticated-orcid":false,"given":"Deborah","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"V\u00e1lkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Clesham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Loron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-3351","authenticated-orcid":false,"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1862-0075","authenticated-orcid":false,"given":"Bernd","family":"Gruhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorinde D.","family":"Hoogenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarl E.","family":"Mooyaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5519-9154","authenticated-orcid":false,"given":"Isabel","family":"Sanchez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pagliuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Simonetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0695-3879","authenticated-orcid":false,"given":"Giorgia","family":"Battipaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5482-8565","authenticated-orcid":false,"given":"Thierry","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette D.","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-0002","authenticated-orcid":false,"given":"Florent","family":"Malard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3914-7806","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Kuball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-2765","authenticated-orcid":false,"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,23]]},"reference":[{"key":"2555_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555\u201362.","journal-title":"Blood"},{"key":"2555_CR2","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76:2462\u20135.","journal-title":"Blood"},{"key":"2555_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1200\/JCO.20.01719","volume":"39","author":"C Schmid","year":"2021","unstructured":"Schmid C, Kuball J, Bug G. Defining the role of donor lymphocyte infusion in high-risk hematologic malignancies. J Clin Oncol. 2021;39:397\u2013418.","journal-title":"J Clin Oncol"},{"key":"2555_CR4","doi-asserted-by":"crossref","unstructured":"Falkenburg JHF, Schmid C, Kolb HJ, Locatelli F, Kuball J, Carreras E et al. Delayed transfer of immune cells or the art of Donor Lymphocyte Infusion (DLI) 2.0. In: Sureda A, Corbacioglu, S, Greco R, Kr\u00f6ger N, Carreras E. (eds) The EBMT handbook 2024; pp 531\u20139.","DOI":"10.1007\/978-3-031-44080-9_59"},{"key":"2555_CR5","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/S2352-3026(24)00098-X","volume":"11","author":"S Pagliuca","year":"2024","unstructured":"Pagliuca S, Schmid C, Santoro N, Simonetta F, Battipaglia G, Guillaume T, et al. Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT. Lancet Haematol. 2024;11:e448\u201358.","journal-title":"Lancet Haematol"},{"key":"2555_CR6","doi-asserted-by":"crossref","unstructured":"Bader P, Kreyenberg H, Bacigalupo A. Documentation of engraftment and chimerism after HCT. In: Sureda, A., Corbacioglu, S, Greco, R., Kr\u00f6ger N, Carreras E. The EBMT handbook 2024; pp 183\u20137.","DOI":"10.1007\/978-3-031-44080-9_21"},{"key":"2555_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2478\/jtim-2023-0136","volume":"12","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yin Z, Liang Z, Bai Y, Zhang T, Yang J, et al. Impacts of cryopreservation on phenotype and functionality of mononuclear cells in peripheral blood and ascites. J Transl Intern Med. 2024;12:51\u201363.","journal-title":"J Transl Intern Med"},{"key":"2555_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0955-3886(00)00123-5","volume":"24","author":"G G\u00fcrman","year":"2001","unstructured":"G\u00fcrman G, Dilek I, Arslan \u00d6, Arat M, Beksa\u00e7 M, Ilhan O, et al. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfus Apher Sci. 2001;24:23\u20138.","journal-title":"Transfus Apher Sci"},{"key":"2555_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.bmt.1704444","volume":"33","author":"P Bader","year":"2004","unstructured":"Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D, et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transpl. 2004;33:815\u201321.","journal-title":"Bone Marrow Transpl"},{"key":"2555_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41409-022-01839-8","volume":"58","author":"N Santoro","year":"2023","unstructured":"Santoro N, Mooyaart JE, Devillier R, Koc Y, Vydra J, Castagna L, et al. Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: a study on behalf of the EBMT Cellular therapy & Immunobiology Working Party. Bone Marrow Transpl. 2023;58:54\u201360.","journal-title":"Bone Marrow Transpl"},{"key":"2555_CR11","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.3760\/cma.j.issn.0366-6999.20141481","volume":"127","author":"CH Yan","year":"2014","unstructured":"Yan CH, Xu LP, Liu DH, Chen H, Wang Y, Liu KY, et al. Immunosuppression for 6\u20138 weeks after modified donor lymphocyte infusion reduced acute graft\u2013versus\u2013host disease without influencing graft\u2013versus\u2013leukemia effect in haploidentical transplant. Chin Med J. 2014;127:3602\u20139.","journal-title":"Chin Med J"},{"key":"2555_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/ctr.12561","volume":"29","author":"CH Yan","year":"2015","unstructured":"Yan CH, Xu LP, Liu DH, Chen H, Wang Y, Wang JZ, et al. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT. Clin Transpl. 2015;29:594\u2013605.","journal-title":"Clin Transpl"},{"key":"2555_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/bmt.2012.144","volume":"48","author":"KKS Abbi","year":"2013","unstructured":"Abbi KKS, Zhu J, Ehmann WC, Epner E, Carraher M, Mierski J, et al. G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation. Bone Marrow Transpl. 2013;48:357\u201362.","journal-title":"Bone Marrow Transpl"},{"key":"2555_CR14","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3390\/jcm9072204","volume":"9","author":"S Lamure","year":"2020","unstructured":"Lamure S, Paul F, Gagez AL, Delage J, Vincent L, Fegueux N, et al. A retrospective comparison of DLI and gDLI for post-transplant treatment. J Clin Med. 2020;9:2204.","journal-title":"J Clin Med"},{"key":"2555_CR15","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1182\/blood-2011-09-380386","volume":"119","author":"CH Yan","year":"2012","unstructured":"Yan CH, Liu DH, Liu KY, Xu LP, Liu YR, Chen H, et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood. 2012;119:3256\u201362.","journal-title":"Blood"},{"key":"2555_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbmt.2010.05.005","volume":"16","author":"EP Alyea","year":"2010","unstructured":"Alyea EP, DeAngelo DJ, Moldrem J, Pagel JM, Przepiorka D, Sadelin M, et al. NCI first international workshop on the biology, prevention and treatment of relapse after allogeneic hematopoietic cell transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies. Biol Blood Marrow Transpl. 2010;16:1037\u201369.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2555_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999163","volume":"13","author":"I Odak","year":"2022","unstructured":"Odak I, Sikora R, Riemann L, Bayir LM, Beck M, Drenker M, et al. Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse. Front Immunol. 2022;13:999163.","journal-title":"Front Immunol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02555-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T14:27:59Z","timestamp":1746714479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02555-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,23]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02555-9","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,23]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CS has received travel expenses or honoraria for participation in advisory boards, symposia or other scientific events by Novartis, Jazz Pharmaceutical, Neovii, Janssen, and Kite. FS institutional consulting fees from BMS\/Celgene, Incyte, Kite\/Gilead; speaker fees from Kite\/Gilead, Incyte; travel support from Kite\/Gilead, Novartis, AstraZeneca, Neovii, Janssen; research funding from Kite\/Gilead, Novartis, BMS\/Celgene. SP has received travel expenses or honoraria for participation in advisory boards, symposia, or other scientific events by Alexion, Novartis, Jazz Pharmaceutical, Therakos, OneLamda, Sobi as well as research funding by JANSSEN HORIZON program. JK has received grants from Novartis, Miltenyi Biotech, and Gadeta. JK was a Gadeta shareholder; patent licenses to Gadeta and Miltenyi Biotech. None of these disclosures construe a potential competitive interest with the research discussed in this article. All other co-authors declare no COI.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The scientific board of the CTIWP of EBMT approved this study. All patients gave written informed consent for the use of their data. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}